Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer


NCT01591590

Interventional

N/A

Active, not recruiting
CORIOLAN
The purpose of this study is to assess whether in a population of patients with advanced colorectal cancer for which no known effective therapy is available, measuring the spontaneous evolution of tumoral metabolic progression index by serial FGD PET-CT and Diffusion MRI can show that tumor growth rate is related to the patient's outcome, and that serial FDG PET-CT and Diffusion MRI are able to measure it.
Jun 30,2012
All
18 Years
N/A
53

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.